Our data highlight that circulating forms of sPD-L1, as well as sB7-H3 and sB7-H4, are emerging as non-invasive predictors of survival in ICI-treated metastatic NSCLC patients, acting independently of their tumor tissue expression. The gene discussed is SPDL1; the disease is neoplasm.